These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32382090)

  • 1. Publisher Correction: Unbalanced Expression of ICOS and PD-1 in Patients with Neuromyelitis Optica Spectrum Disorder.
    Xue Q; Li X; Gu Y; Wang X; Wang M; Tian J; Duan X; Gao H; Ji X; Yan X; Dong W; Fang Q; Zhang X
    Sci Rep; 2020 May; 10(1):7930. PubMed ID: 32382090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unbalanced Expression of ICOS and PD-1 in Patients with Neuromyelitis Optica Spectrum Disorder.
    Xue Q; Li X; Gu Y; Wang X; Wang M; Tian J; Duan X; Gao H; Ji X; Yan X; Dong W; Fang Q; Zhang X
    Sci Rep; 2019 Oct; 9(1):14130. PubMed ID: 31575949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders.
    Fan X; Jiang Y; Han J; Liu J; Wei Y; Jiang X; Jin T
    Mediators Inflamm; 2016; 2016():3678152. PubMed ID: 27057097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Publisher Correction: Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder.
    Lim ET; Uddin M; De Rubeis S; Chan Y; Kamumbu AS; Zhang X; D'Gama AM; Kim SN; Hill RS; Goldberg AP; Poultney C; Minshew NJ; Kushima I; Aleksic B; Ozaki N; Parellada M; Arango C; Penzol MJ; Carracedo A; Kolevzon A; Hultman CM; Weiss LA; Fromer M; Chiocchetti AG; Freitag CM; ; Church GM; Scherer SW; Buxbaum JD; Walsh CA
    Nat Neurosci; 2020 Sep; 23(9):1176. PubMed ID: 32665711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Publisher Correction: Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells.
    Bardhan K; Aksoylar HI; Le Bourgeois T; Strauss L; Weaver JD; Delcuze B; Charest A; Patsoukis N; Boussiotis VA
    Sci Rep; 2020 Sep; 10(1):15905. PubMed ID: 32963251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Publisher Correction: Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma.
    Ribas A; Lawrence D; Atkinson V; Agarwal S; Miller WH; Carlino MS; Fisher R; Long GV; Hodi FS; Tsoi J; Grasso CS; Mookerjee B; Zhao Q; Ghori R; Moreno BH; Ibrahim N; Hamid O
    Nat Med; 2019 Aug; 25(8):1319. PubMed ID: 31267021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of neuromyelitis optica spectrum disorder after more than twenty years of systemic sclerosis.
    Hernández ZM; Cohen BA; Derwenskus J
    Mult Scler Relat Disord; 2012 Oct; 1(4):202-3. PubMed ID: 25877268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Publisher Correction: Association of PPM1G methylation with risk-taking in alcohol use disorder.
    Park CI; Kim HW; Hwang SS; Kang JI; Kim SJ
    Sci Rep; 2020 Jun; 10(1):10163. PubMed ID: 32555270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher frequency of brain abnormalities in neuromyelitis optica spectrum disorder patients without primary Sjögren's syndrome.
    Gu LN; Zhang M; Zhu H; Liu JY
    Neural Regen Res; 2016 Oct; 11(10):1633-1637. PubMed ID: 27904495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Publisher Correction: Primary functional brain connections associated with melancholic major depressive disorder and modulation by antidepressants.
    Ichikawa N; Lisi G; Yahata N; Okada G; Takamura M; Hashimoto RI; Yamada T; Yamada M; Suhara T; Moriguchi S; Mimura M; Yoshihara Y; Takahashi H; Kasai K; Kato N; Yamawaki S; Seymour B; Kawato M; Morimoto J; Okamoto Y
    Sci Rep; 2020 Oct; 10(1):17650. PubMed ID: 33057026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics of Patients With Neuromyelitis Optica Spectrum Disorders With Early Onset.
    Fragoso YD; Sousa NAC; Saad T; Alves-Leon SV; Pimentel MLV; Goncalves MVM; Stella CV; Diniz DS; Santos GC; Gomes S; Adoni T; Anacleto A; Claudino R; Malfetano FR; Winckler TCD; Damasceno A; Eboni ACB; Farinhas JGD; Mota RSS
    J Child Neurol; 2019 Aug; 34(9):487-490. PubMed ID: 31012355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapies for neuromyelitis optica spectrum disorder.
    Levy M; Fujihara K; Palace J
    Lancet Neurol; 2021 Jan; 20(1):60-67. PubMed ID: 33186537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain MRI Findings in Pediatric-Onset Neuromyelitis Optica Spectrum Disorder: Challenges in Differentiation from Acute Disseminated Encephalomyelitis.
    Bulut E; Karakaya J; Salama S; Levy M; Huisman TAGM; Izbudak I
    AJNR Am J Neuroradiol; 2019 Apr; 40(4):726-731. PubMed ID: 30846436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder.
    Pula JH; Kattah JC; Keung B; Wang H; Daily J
    J Neurol Sci; 2014 Oct; 345(1-2):209-12. PubMed ID: 25125046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica spectrum disorder with increased aquaporin-4 microparticles prior to autoantibodies in cerebrospinal fluid: a case report.
    Bejerot S; Hesselmark E; Mobarrez F; Wallén H; Hietala MA; Nybom R; Wetterberg L
    J Med Case Rep; 2019 Jan; 13(1):27. PubMed ID: 30696485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Publisher Correction: Process-based framework for precise neuromodulation.
    Lubianiker N; Goldway N; Fruchtman-Steinbok T; Paret C; Keynan JN; Singer N; Cohen A; Kadosh KC; Linden DEJ; Hendler T
    Nat Hum Behav; 2019 Jul; 3(7):760. PubMed ID: 31168064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Publisher Correction: Optimizing the dynamics of protein expression.
    Trösemeier JH; Rudorf S; Loessner H; Hofner B; Reuter A; Schulenborg T; Koch I; Bekeredjian-Ding I; Lipowsky R; Kamp C
    Sci Rep; 2020 Apr; 10(1):6107. PubMed ID: 32246082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Publisher Correction: Cortical encoding of speech enhances task-relevant acoustic information.
    Rutten S; Santoro R; Hervais-Adelman A; Formisano E; Golestani N
    Nat Hum Behav; 2019 Oct; 3(10):1125. PubMed ID: 31462763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder.
    Mealy MA; Cook LJ; Pache F; Velez DL; Borisow N; Becker D; Arango JAJ; Paul F; Levy M
    Mult Scler Relat Disord; 2018 Jul; 23():78-82. PubMed ID: 29783157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
    Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
    Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.